Immunoreactivity assay for α-particle emitting monoclonal antibody constructs Journal Article


Authors: Bonavia, A. S.; McDevitt, M. R.; Curcio, M. J.; Scheinberg, D. A.
Article Title: Immunoreactivity assay for α-particle emitting monoclonal antibody constructs
Abstract: Clinical trials using α-particle radiolabeled antibodies require a rapid and reproducible assay of the immunoreactivity of drugs. While live cell assays are typically used to determine the immunoreactive drug fraction, a fixed cell assay may replace the traditional live cell assay and offer the advantages of rapidity, easy availability and consistency for qualifying drugs for preclinical or clinical studies. We have identified optimal cell fixation and immunoreactivity assay conditions and have validated them by performing the fixed-cell assay in clinical trials. © 2005 Elsevier Ltd. All rights reserved.
Keywords: controlled study; human cell; nonhuman; animal cell; mouse; animals; mice; cell line; cell assay; immunoreactivity; monoclonal antibody; antibodies, monoclonal; isotope labeling; bioassay; radioisotopes; immunoglobulin g1 antibody; cells; medical applications; alpha radiation; alpha particles; drug products; actinium 225; bismuth 213; ac-225; α-particles; bi-213; immunoreactivity assay; particulate emissions
Journal Title: Applied Radiation and Isotopes
Volume: 64
Issue: 4
ISSN: 0969-8043
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2006-04-01
Start Page: 470
End Page: 474
Language: English
DOI: 10.1016/j.apradiso.2005.11.004
PUBMED: 16352433
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "CODEN: ARISE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael R Mcdevitt
    144 Mcdevitt
  2. Michael J Curcio
    28 Curcio